Golimumab, Ustekinumab, and Dronedarone Hydrochloride Use (by Quarter)

    Basic Details
    Date Posted
    Thursday, December 13, 2012
    Status
    Complete
    Medical Product
    dronedarone HCL
    golimumab
    ustekinumab
    Description

    Summary table assessment of the use of Golimumab, Ustekinumab, and Dronedarone Hydrochloride by quarter. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table.Summary tables are precompiled stratified counts. Queries were executed in August 2011. This report includes data from 15 Data Partners.

    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

     

    Additional Details
    FDA Center
    CDER
    Time Period
    2009 - 2010
    Study Type
    Summary Table
    Assessment Type
    Exploratory Analyses
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)